In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection

Despite the development of direct-acting antivirals (DAAs), hepatitis C virus (HCV) infection remains a major cause for liver disease and cancer worldwide. Entry inhibitors block virus host cell entry and, therefore, prevent establishment of chronic infection and liver disease. Due to their unique m...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antiviral Res
Hlavní autoři: Mailly, Laurent, Wrensch, Florian, Heydmann, Laura, Fauvelle, Catherine, Brignon, Nicolas, Zeisel, Mirjam B., Pessaux, Patrick, Keck, Zhen-yong, Schuster, Catherine, Fuerst, Thomas R., Foung, Steven K.H., Baumert, Thomas F.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463510/
https://ncbi.nlm.nih.gov/pubmed/30599173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2018.12.018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky